| 000 | 01924 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513054702.0 | ||
| 264 | 0 | _c19940728 | |
| 008 | 199407s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.91.13.6088 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrojan, J | |
| 245 | 0 | 0 |
_aGene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJun 1994 |
||
| 300 |
_a6088-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xanalysis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 | _aRestriction Mapping |
| 650 | 0 | 4 |
_aTeratocarcinoma _ximmunology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJohnson, T R | |
| 700 | 1 | _aRudin, S D | |
| 700 | 1 | _aBlossey, B K | |
| 700 | 1 | _aKelley, K M | |
| 700 | 1 | _aShevelev, A | |
| 700 | 1 | _aAbdul-Karim, F W | |
| 700 | 1 | _aAnthony, D D | |
| 700 | 1 | _aTykocinski, M L | |
| 700 | 1 | _aIlan, J | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 91 _gno. 13 _gp. 6088-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.91.13.6088 _zAvailable from publisher's website |
| 999 |
_c8015449 _d8015449 |
||